Haisco Pharmaceutical Group Co., Ltd. (002653.SZ)

CNY 34.83

(-0.46%)

Market Cap (In CNY)

39 Billion

Revenue (In CNY)

3.35 Billion

Net Income (In CNY)

295.11 Million

Avg. Volume

3.3 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
18.59-40.66
PE
-
EPS
-
Beta Value
0.072
ISIN
CNE100001BC7
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Ms. Xiu Lian Fan
Employee Count
-
Website
https://www.haisco.com
Ipo Date
2012-01-17
Details
Haisco Pharmaceutical Group Co., Ltd., together with its subsidiaries, develops, produces, and sells drugs in China. The company offers small-volume injections, freeze-dried powder injections, powder injections, large-volume injections, active pharmaceutical ingredient, etc. for various therapeutic fields, including anti-infective, digestive system, blood system, nervous system, parenteral nutrition, antibiotics, first aid, anesthetics, and tumor; and tablets, capsules, granules, and ointments in the fields of cardiovascular, anti-infection, digestive system, CNS system, diabetes, and hepatic diseases. The company was formerly known as Xizang Haisco Pharmaceutical Group Co., Ltd. and changed its name to Haisco Pharmaceutical Group Co., Ltd. in March 2016. Haisco Pharmaceutical Group Co., Ltd. was founded in 2000 and is based in Shannan, China.